Oral disintegrating tablet

An oral disintegrating tablet having 150-740 mg comprising

• 20-80 mg angiotensin II receptor antagonist telmisartan
• 20-80 mg basic excipient selected from the group consisting of alkali metal hydroxides, basic amino acids and meglumine
• 20-350 mg filler selected from the group consisting of cellulose, dibasic calcium phosphate anhydrous, erythritol, mannitol, microcrystalline cellulose, corn starch, and pregelatinized starch,
• 20-150 mg coating agent of the first granulate selected from corn starch, pregelatinized starch, lactose, D-mannitol, erythritol or microcrystalline cellulose
• 5-50 mg disintegrant selected from the group consisting of sodium starch glycolate, crospovidone, corn starch and pregelatinized starch
• 2-20 mg surfactant/emulsifier poloxamer 188
• 0.5-10 mg sweetener
• 0.12-1.2 mg flow control agent light anhydrous silicic acid
• 0-0.01 mg lubricant
• 0-0.01 mg dye or pigment
• wherein
• the basic excipient is meglumine;
• the filler is selected from the group consisting of cellulose, dibasic calcium phosphate anhydrous, erythritol, mannitol, microcrystalline cellulose corn starch and pregelatinized starch;
• the disintegrant is selected from the group consisting of sodium starch glycolate, crospovidone (cross-linked polyvinylpyrrolidone), corn starch and pregelatinized starch;
• the coating agent of the first granulate is selected from corn starch or pregelatinized starch;
• the lubricant is magnesium stearate;
• the sweetener is saccharin sodium;
• the dye or pigment is an iron oxide.